Drugs / 18F-CP18
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01766622 | Nov 2012 → Jul 2013 | fallopian tube cancer, ovarian cancer | National Institutes of Health Clinical Center (CC) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-CP18 | “18F-CP18 is a chemical designed for use in imaging studies.” NCT01766622 ↗ |
| Modality | Diagnostic / imaging agent | “18F-CP18 is a chemical designed for use in imaging studies.” NCT01766622 ↗ |
| Route | Intravenous | “IV (in the vein) at baseline” NCT01766622 ↗ |